- KOWA: Multicenter, multinational, randomized, double-blind, placebo-controlled event-driven effiacacy and safety study of XXXXX to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes.
For more information or to volunteer email or call 757-966-4520.
Virginia Endocrinology Research | 757-966-4520 | 3205 Churchland Blvd., Chesapeake, VA 23321 | www.vaendoresearch.org | Email Us